ERBB2 and neoplasm: Another study demonstrated the efficacy of affibody ZHER2:342-conjugated AgNPs (AgNPs-HER2) in cancer therapy by investigating these nanoparticles on HER2 overexpressing cancer cells and on a xenograft tumor model.